Melnick, Kaitlyn
Dastmalchi, Farhad
Mitchell, Duane
Rahman, Maryam
Sayour, Elias J. http://orcid.org/0000-0002-5309-3197
Funding for this research was provided by:
National Institutes of Health (R37CA251978, R01CA195563, R01CA175517, K08NS099484, K08CA199224)
Rally Foundation
CureSearch for Children's Cancer (Catapult Award)
Florida DOH (LLB Award, BC Award)
Article History
Received: 24 December 2020
Accepted: 21 May 2021
First Online: 8 June 2021
Declarations
:
: This manuscript discusses patented technologies by EJS and DAM that are under option to license by iOncologi, Inc., and patents by DAM that have been licensed to Immunomic Therapeutics, Inc., Annias Immunotherapeutics, Inc., and Celldex, Inc.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.